Factors associated with utilization of neoadjuvant chemotherapy in charlson comorbidity zero non-metastatic muscle-invasive bladder cancer patients

Factors associated with utilization of neoadjuvant chemotherapy in charlson comorbidity zero non-metastatic muscle-invasive bladder cancer patients

ABSTRACT Background: Guideline-based best practice treatment for muscle invasive bladder cancer (MIBC) involves neoadjuvant chemotherapy followed by radical cystectomy (NACRC). Prior studies have shown that a minority of patients receive NACRC and older age and renal function are drivers of non-rec...

Full description

Bibliographic Details
Main Authors:	Daniel Au, Eugene K. Lee, Taiye O. Popoola, William P. Parker, Jarron M. Saint Onge, Shellie D. Ellis
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Urologia 2021-07-01
Series:	International Brazilian Journal of Urology
Subjects:	Urinary Bladder Neoplasm Cystectomy Neoadjuvant Therapy
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382021000400803&tlng=en

Similar Items

Oncological outcomes of visibly complete transurethral resection prior to neoadjuvant chemotherapy for bladder cancer
by: Bryce Baird, et al.
Published: (2023-08-01)

Referral for “Neoadjuvant Chemotherapy” for Muscle-Invasive Bladder Cancer to a Multidisciplinary Board: Patterns, Management and Outcomes
by: Dellis A, et al.
Published: (2021-07-01)

Cystectomy vs. bladder preservation after neoadjuvant chemotherapy in muscle-invasive bladder cancer: A tertiary medical center experience
by: Ibrahim El Halabi, et al.
Published: (2020-01-01)

Neoadjuvant Immunotherapy for Muscle-Invasive Bladder Cancer
by: Arthur Peyrottes, et al.
Published: (2021-07-01)

Neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer: The likelihood of initiation and completion
by: Ahmed Eldefrawy, et al.
Published: (2012-01-01)

The Current State of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
by: Oktay Üçer
Published: (2016-04-01)

Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer and Its Impact on Surgical Morbidity and Oncological Outcomes: A Real-World Experience
by: Thanh-Tuan Nguyen, et al.
Published: (2018-09-01)

Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial
by: F. J. Hinsenveld, et al.
Published: (2021-10-01)

Approaches to Clinical Complete Response after Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer: Possibilities and Limitations
by: Hye Won Lee, et al.
Published: (2023-02-01)

Impacts of Neoadjuvant Chemotherapy on Perioperative Outcomes in Patients with Bladder Cancer Treated with Radical Cystectomy: A Single High-Volume Center Experience
by: Flavia Proietti, et al.
Published: (2024-02-01)

Comparison of trimodality therapy and neoadjuvant chemotherapy combined with radical cystectomy for the survival of muscle-invasive bladder cancer: a population-based analysis
by: Yi-Xin Zhou, et al.
Published: (2023-10-01)

Effect of Neoadjuvant Chemotherapy on Complications, in-Hospital Mortality, Length of Stay and Total Hospital Costs in Bladder Cancer Patients Undergoing Radical Cystectomy
by: Benedikt Hoeh, et al.
Published: (2022-02-01)

Metastatic Melanoma to the Bladder: Case Report and Review of the Literature
by: Rohit V. Patil, et al.
Published: (2017-02-01)

Risk and predictors of patients receiving neoadjuvant chemotherapy followed by radical cystectomy or transurethral resection alone for muscle-invasive bladder cancer: A single-institute experience
by: Pei-Jhang Chiang, et al.
Published: (2022-01-01)

Surface-Enhanced Raman Spectroscopy of Pretreated Plasma Samples Predicts Disease Recurrence in Muscle-Invasive Bladder Cancer Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy
by: Qian H, et al.
Published: (2022-04-01)

Central Venous Access and the Risk for Thromboembolic Events in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer
by: Harriet Rydell, et al.
Published: (2022-08-01)

Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? Opinion: No
by: Timur Mitin

The long-term efficacy of one-shot neoadjuvant intra-arterial chemotherapy combined with radical cystectomy versus radical cystectomy alone for bladder cancer: a propensity-score matching study
by: Wasilijiang Wahafu, et al.
Published: (2019-11-01)

Radical Cystectomy is the best choice for most patients with muscle-invasive bladder cancer? Opinion: Yes
by: Leonardo L. Monteiro, et al.

Surgery Versus Perioperative Chemotherapy In Non Metastatic Muscle Invasive Bladder Carcinoma
by: Sarah Ali, et al.
Published: (2022-01-01)

Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer
by: Filipe LF. Carvalho, et al.
Published: (2020-07-01)

Adequate Pelvic Lymph Node Dissection in Radical Cystectomy in the Era of Neoadjuvant Chemotherapy: A Meta-Analysis and Systematic Review
by: Krystian Kaczmarek, et al.
Published: (2023-08-01)

Circulating Tumor Cells Predict Response of Neoadjuvant Chemotherapy in Patients with Bladder Cancer: A Preliminary Study
by: Yu-Cing Jhuo, et al.
Published: (2023-03-01)

A Retrospective Analysis of the De Ritis Ratio in Muscle Invasive Bladder Cancer, with Focus on Tumor Response and Long-Term Survival in Patients Receiving Neoadjuvant Chemotherapy and in Chemo Naïve Cystectomy Patients—A Study of a Clinical Multicentre Database
by: Victoria Eriksson, et al.
Published: (2022-10-01)

Combined Modality Bladder-Sparing Therapy for Muscle-Invasive Bladder Cancer: How (Should) We Do It? A Narrative Review
by: Artur Lemiński, et al.
Published: (2023-02-01)

Predicting Complete Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
by: Hiroko Miyagi, et al.
Published: (2022-12-01)

Thromboembolic Events in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Study of Renal Impairment in Relation to Potential Thromboprophylaxis
by: Harriet Rydell, et al.
Published: (2022-11-01)

Evaluating residual tumor after neoadjuvant chemotherapy for muscle-invasive urothelial bladder cancer: diagnostic performance and outcomes using biparametric vs. multiparametric MRI
by: Sungmin Woo, et al.
Published: (2023-11-01)

The Risk of Thromboembolism in Patients with Muscle Invasive Bladder Cancer before and after Cystectomy Depending on Blood Group and Neoadjuvant Chemotherapy—A Multicentre Retrospective Cohort Study
by: Emma Schulz Hägersten, et al.
Published: (2023-09-01)

Impact of Lymphovascular Invasion on Prognosis in the Patients with Bladder Cancer—Comparison of Transurethral Resection and Radical Cystectomy
by: Kei Yoneda, et al.
Published: (2021-02-01)

Salivary cotinine level and treatment response in muscle invasive bladder cancer: A pilot study
by: Jeromy W. Gotschall, et al.
Published: (2023-03-01)

Influence of Neoadjuvant Chemotherapy on Survival Outcomes of Radical Cystectomy in Pathologically Proven Positive and Negative Lymph Nodes
by: Krystian Kaczmarek, et al.
Published: (2023-10-01)

Neoadjuvant chemotherapy versus cystectomy in management of stages II, and III urinary bladder cancer
by: Mohammed A. Osman, et al.
Published: (2014-12-01)

Survival Outcomes of Patients with Pathologically Proven Positive Lymph Nodes at Time of Radical Cystectomy with or without Neoadjuvant Chemotherapy
by: Guillaume Ploussard, et al.
Published: (2020-06-01)

Proteomic Profiling of Tissue Exosomes Indicates Continuous Release of Malignant Exosomes in Urinary Bladder Cancer Patients, Even with Pathologically Undetectable Tumour
by: Maria Eldh, et al.
Published: (2021-06-01)

Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
by: Kari T. Syvänen, et al.
Published: (2014-05-01)

Cystectomy with orthotopic neobladder ; an option for giant leiomyoma of urinary bladder : A case report and the review of literature
by: Kamal Jeet Singh, et al.
Published: (2004-01-01)

A Rare Case: Sporadic Bladder Paraganglioma
by: Hakan Ercil, et al.
Published: (2013-08-01)

Management of Localized Muscle-Invasive Bladder Cancer from a Multidisciplinary Perspective: Current Position of the Spanish Oncology Genitourinary (SOGUG) Working Group
by: Antonio Gómez Caamaño, et al.
Published: (2021-12-01)

Comparing fluorodeoxyglucose positron emission tomography with computed tomography in staging for nodal and distant metastasis in urothelial/bladder cancer
by: Mohammed Al‐Zubaidi, et al.
Published: (2024-04-01)